HCA Healthcare, Inc. $HCA Stock: TD Waterhouse Canada Inc. Decreases Position

Posted by Brian Himes on Oct 20th, 2026

TD Waterhouse Canada Inc. lowered its holdings in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 18.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 12,791 shares of the company’s stock after selling 2,855 shares during the period. TD Waterhouse Canada Inc.’s holdings in HCA Healthcare were worth $5,416,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Banque Pictet & Cie SA purchased a new position in HCA Healthcare in the third quarter valued at about $4,221,000. Cyndeo Wealth Partners LLC purchased a new stake in shares of HCA Healthcare in the third quarter worth about $266,000. Chemistry Wealth Management LLC boosted its position in shares of HCA Healthcare by 613.7% in the third quarter. Chemistry Wealth Management LLC now owns 5,096 shares of the company’s stock worth $2,175,000 after buying an additional 4,382 shares during the period. Legacy Wealth Partners LLC acquired a new stake in shares of HCA Healthcare in the third quarter valued at about $204,000. Finally, V Square Quantitative Management LLC raised its holdings in shares of HCA Healthcare by 8.2% during the 3rd quarter. V Square Quantitative Management LLC now owns 1,183 shares of the company’s stock valued at $505,000 after buying an additional 90 shares during the period. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

NYSE:HCA opened at $455.53 on Tuesday. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52. The business’s 50-day simple moving average is $427.22 and its 200 day simple moving average is $418.81. The stock has a market cap of $98.62 billion, a price-to-earnings ratio of 15.25, a price-to-earnings-growth ratio of 1.55 and a beta of 1.10.

HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%. The firm had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same quarter in the prior year, the business posted $6.84 earnings per share. HCA Healthcare’s revenue for the quarter was up 8.7% on a year-over-year basis. On average, equities research analysts predict that HCA Healthcare, Inc. will post 29.45 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th were paid a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Wednesday, September 16th. HCA Healthcare’s dividend payout ratio is 10.45%.

Analyst Upgrades and Downgrades

Several research firms recently commented on HCA. TD Cowen boosted their price target on HCA Healthcare from $431.00 to $460.00 and gave the stock a “buy” rating in a research report on Monday, October 12th. Jefferies Financial Group set a $450.00 price objective on shares of HCA Healthcare in a research report on Tuesday, July 14th. Truist Financial dropped their price objective on shares of HCA Healthcare from $535.00 to $495.00 and set a “buy” rating on the stock in a research note on Monday, July 27th. JPMorgan Chase & Co. reduced their target price on shares of HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating on the stock in a research report on Thursday, August 20th. Finally, The Goldman Sachs Group decreased their target price on shares of HCA Healthcare from $558.00 to $485.00 and set a “buy” rating for the company in a research note on Tuesday, July 28th. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $467.61.

Get Our Latest Stock Report on HCA

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc is a healthcare services company that operates hospitals, ambulatory surgery centers, emergency care facilities, physician practices and other healthcare sites. Its facilities provide a broad range of services, including acute and emergency care, surgery, cardiology, oncology, women’s and children’s services, behavioral health and outpatient care.

The company serves patients primarily across the United States through a network of healthcare facilities in numerous states.